Major Pharmaceutical Firms Receive FDA Warning Letters Amid Drug Advertising Crackdown

Written by Emily J. Thompson, Senior Investment Analyst

Source: Yahoo Finance

Updated: Sep 17 2025

0mins

Source: Yahoo Finance

FDA's Enforcement on Drug Advertisements: The FDA has initiated a crackdown on misleading drug advertisements, sending thousands of warning letters to pharmaceutical companies for unlawful marketing practices, including the sale of unapproved drugs and false claims.
Companies Targeted: Notable companies like Hims & Hers, Eli Lilly, and Novo Nordisk received warnings for various violations, including misleading advertisements related to weight-loss drugs and overstated effectiveness in DTC ads.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Major Pharmaceutical Firms Receive FDA Warning Letters Amid Drug Advertising Crackdown

About the author

Top News

Ford Announces $19.5B EV Restructuring Charges

Fed Cuts Interest Rates Amid Economic Concerns

SpaceX Targets $800 Billion Valuation in Secondary Sale

U.S. Consumer Sentiment Slightly Improves in December

Related Articles

Athletic Brewing Launches New Non-Alcoholic Beers, Captures 52% Market Share

Synchrony Extends Partnership with AmSpa, Offering Preferred Transaction Rates

People Also Watch